Archive

Low-energy amplitude-modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma.

This single-site feasibility trial evaluated repeated 90-minute amplitude-modulated EMF exposure (AutEMdev) in 66 patients with advanced hepatocellular carcinoma. The primary focus was safety and hemodynamic variability during exposure, with exploratory outcomes including quality of life, survival, and tumor…

Safety and Efficacy of amplitude-modulated radiofrequency electromagnetic fields in advanced hepatocellular carcinoma

This pooled case series evaluated amplitude-modulated 27.12 MHz RF EMF delivered via the TheraBionic P1 device (3 hours daily) in patients with advanced hepatocellular carcinoma, comparing outcomes to historical controls. The authors report longer median overall survival for Child-Pugh A patients versus comparable…

Radiofrequency-assisted liver resections: comparison of open and laparoscopic techniques.

This single-institution cohort compared radiofrequency-assisted laparoscopic liver resection with open resection over 5 years (47 vs 87 patients). Laparoscopy was associated with lower blood loss and similar 5-year overall and disease-free survival compared with open surgery. The authors conclude the laparoscopic…